Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

Lindsay, J. O.; Whelan, K.; Stagg, A. J.; Gobin, P.; Al-Hassi, H. O.; Rayment, N.; Kamm, M. A.; Knight, S. C.; Forbes, A.
March 2006
Gut;Mar2006, Vol. 55 Issue 3, p348
Academic Journal
Background and aims: The intestinal microbiota play a pivotal role in the inflammation associated with Crohn's disease through their interaction with the mucosal immune system. Some bifidobacteria species are immunoregulatory and induce increased dendritic cell interleukin 10 (IL-10) release in vitro. Fructooligosaccharides (FOS) increase faecal and mucosal bifidobacteria in healthy volunteers. The aim of this study was to assess the effect of FOS administration on disease activity, bifidobacteria concentrations, and mucosal dendritic cell function in patients with moderately active Crohn's disease. Patients and methods: Ten patients with active ileocolonic Crohn's disease received 15 g of FOS for three weeks. Disease activity was measured using the Harvey Bradshaw index. Faecal and mucosal bifidobacteria were quantified by fluorescence in situ hybridisation, and mucosal dendritic cell IL-10 and Toll-like receptor (TLR) expression were assessed by flow cytometry of dissociated rectal biopsies. Results: FOS induced a significant reduction in the Harvey Bradshaw index from 9.8 (SD 3.1) to 6.9 (3.4) (p<0.01). There was a significant increase in faecal bifidobacteria concentration from 8.8 (0.9) log10 to 9.4 (0.9) log10 cells/g dry faeces (p<0.001). The percentage of IL-10 positive dendritic cells increased from 30 (12)% to 53 (10)% (p = 0.06). Finally, the percentage of dendritic cells expressing TLR2 and TLR4 increased from 1.7 (1.7)% to 36.8 (15.9)% (p = 0.08) and from 3.6 (3.6)% to 75.4 (3.4)% (p<0.001), respectively. Conclusions: FOS supplementation increases faecal bifidobacteria concentrations and modifies mucosal dendritic cell function. This novel therapeutic strategy appears to decrease Crohn's disease activity in a small open label trial and therefore warrants further investigation.


Related Articles

  • CD40 and CD86 Upregulation With Divergent CMRF44 Expression on Blood Dendritic Cells in Inflammatory Bowel Diseases. Vuckovic, Slavica; Florin, Timothy H. J.; Khalil, Dalia; Zhang, Min F.; Patel, Kalpana; Hamilton, Iona; Hart, Derek N. J. // American Journal of Gastroenterology;Oct2001, Vol. 96 Issue 10, p2946 

    OBJECTIVE: Dendritic cells (DC) are the only antigen-presenting cells that can activate naïve T lymphocytes and initiate a primary immune response. They are also thought to have a role in immune tolerance. DC traffic from the blood to peripheral tissue where they become activated. They then...

  • Innate immunity in the pathogenesis and therapy of IBD. Sartor, R. Balfour // Journal of Gastroenterology;2003 Supplement 15, Vol. 38, p43 

    Studies the innate immunity in the pathogenesis and therapy of inflammatory bowel disease. Role of endogenous interleukin-10 in regulating antigen presenting cells and dendritic cell functions; Innate immune cell activities of a number of intestinal cells; Secretion of a characteristic profile...

  • Macrophages and Dendritic Cells Emerge in the Liver during Intestinal Inflammation and Predispose the Liver to Inflammation. Mikami, Yohei; Mizuno, Shinta; Nakamoto, Nobuhiro; Hayashi, Atsushi; Sujino, Tomohisa; Sato, Toshiro; Kamada, Nobuhiko; Matsuoka, Katsuyoshi; Hisamatsu, Tadakazu; Ebinuma, Hirotoshi; Hibi, Toshifumi; Yoshimura, Akihiko; Kanai, Takanori // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    The liver is a physiological site of immune tolerance, the breakdown of which induces immunity. Liver antigen-presenting cells may be involved in both immune tolerance and activation. Although inflammatory diseases of the liver are frequently associated with inflammatory bowel diseases, the...

  • Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. Braat, Henri; de Jong, Esther C.; van den Brande, Jan M. H.; Kapsenberg, Martien L.; Peppelenbosch, Maikel P.; van Tol, Eric A. F.; van Deventer, Sander J. H. // Journal of Molecular Medicine;Mar2004, Vol. 82 Issue 3, p197 

    The reaction of the intestinal immune system to intestinal bacteria shows striking differences between various bacterial strains. Whereas Klebsiella pneumoniae induces a fierce proinflammatory reaction, the probiotic strain Lactobacillus rhamnosus has clear anti-inflammatory effect in...

  • Ontogeny and phagocytic function of baboon lung dendritic cells. Awasthi, Shanjana; Wolf, Roman; White, Gary // Immunology & Cell Biology;Jul2009, Vol. 87 Issue 5, p419 

    Dendritic cells (DCs) are the most potent antigen-presenting cells, but the ontogeny and functions of lung DCs are not known during prenatal period. Here, we isolated lung DC population from fetal (125–175 days of gestation age) and adult baboons. The cells were stained with...

  • Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Baumgart, D. C.; Metzke, D.; Schmitz, J.; Scheffold, A.; Sturm, A.; Wiedenmann, B.; Dignass, A. U. // Gut;Feb2005, Vol. 54 Issue 2, p228 

    Background: Breakdown of tolerance against the commensal microflora is believed to be a major factor in the pathogenesis of inflammatory bowel disease (IBD). Dendritic cells (DC) have been implicated in this process in various animal models, but data on human DC in IBD are very limited. Aim: To...

  • Role of mucosal dendritic cells in inflammatory bowel disease. Niess, Jan Hendrik; Lashner, Bret // World Journal of Gastroenterology;9/7/2008, Vol. 14 Issue 33, p5138 

    The gastrointestinal innate and adaptive immune system continuously faces the challenge of potent stimuli from the commensal microflora and food constituents. These local immune responses require a tight control, the outcome of which is in most cases the induction of tolerance. Local T cell...

  • Autophagy gets the ‘NOD’ to enhance bacterial handling and antigen presentation. Shin, Jin Na; Eissa, N. Tony // Immunology & Cell Biology;May/Jun2010, Vol. 88 Issue 4, p343 

    In this article the authors discuss the study about autophagy that gets the nucleotide-binding oligermization domaincontaining (NOD) to enhance bacterial handling and antigen presentation. They cites the study of R. Cooney which shows that NOD2 induces autophagy in human dendritic cells that...

  • Prostaglandin E2—EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion. Chengcan Yao; Sakata, Daiji; Esaki, Yoshiyasu; Youxian Li; Matsuoka, Toshiyuki; Kuroiwa, Kenji; Sugimoto, Yukihiko; Narumiya, Shuh // Nature Medicine;Jun2009, Vol. 15 Issue 6, p633 

    Two distinct helper T (TH) subsets, TH1 and TH17, mediate tissue damage and inflammation in animal models of various immune diseases such as multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases and allergic skin disorders. These experimental findings, and the implication of...


Read the Article


Sign out of this library

Other Topics